# Electroacupuncture for Chemotherapy-Induced GI Symptom Clusters in Breast Cancer

> **NCT06952920** · PHASE3 · RECRUITING · sponsor: **Jiuda Zhao** · enrollment: 388 (estimated)

## Conditions studied

- Standard Quadruple Antiemetic Therapy
- Electroacupuncture
- Chemotherapy-induced Gastrointestinal Symptom Cluster

## Interventions

- **DEVICE:** electroacupuncture
- **DRUG:** standard quadruple antiemetic therapy
- **DEVICE:** sham electroacupuncture
- **DRUG:** standard quadruple antiemetic therapy

## Key facts

- **NCT ID:** NCT06952920
- **Lead sponsor:** Jiuda Zhao
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-21
- **Primary completion:** 2028-06-30
- **Final completion:** 2028-06-30
- **Target enrollment:** 388 (ESTIMATED)
- **Last updated:** 2025-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06952920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06952920, "Electroacupuncture for Chemotherapy-Induced GI Symptom Clusters in Breast Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06952920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*